Margin beat masks volume softness; execution risk on domestic turnaround

Delivered OPM 21.1%, NPM 14.7%, exceeding guided range

Sales up 15.4% YoY, OPM up ~130bps vs prior year estimate; efficiency claim plausible but exact mechanism unspecified

Aligns with prior guidance of ₹250-400 Cr in first 9 months; conservative positioning

Delayed from prior timelines (Nov 2025 → Aug → Sept); third delay flagged by analysts; dry run confirmed by MD

Domestic revenue flat despite price hikes; restructuring plan is generic (new team, distributors, warehouses); no competitive edge articulated

Aica took 40% stake, nominated board members mid-July; management said no roadmap yet, tech transfer 'don't know' timeline

Shifted from Nov 2025 → Aug 2026 → Sep 2026. 'Family problem' now resolved, blamed rain + construction complexity. Dry run active; third delay erodes credibility.

Prior ₹250-400 Cr (9 months), now ₹250-300 Cr FY27 (at 30% utilization end-of-year). Conservative but achievable; FY28 target ₹600-700 Cr maintained.

Mgmt now says 2-3 quarters from Q1 (Q2-Q3) to see results, not immediate. Restructuring team, distributors, warehouses, but no competitive edge disclosed vs 4-year flat run.

40% stake taken, board seats filled, but 'nothing as of now.' Tech transfer 'don't know' timeline; acrylic orders 'hopeful' but unconfirmed. More financial anchor than operational catalyst.

Guided 19-20% EBITDA vs FY26 expectation ~22%. Delivered 21.1% OPM suggests room, but management withholding upside until new plant stabilizes.

No inventory gain; efficiency and higher sales reducing unit costs. Margins will remain 19-20% plus when new plant starts.

Commercial production first week of September. Delayed for construction, now final stages.

It takes 2-3 quarters to revamp. New team, distributors, warehouses being set up. Results from Q3 onwards.

Delays due to family problem now resolved, construction issues (rain). Maximum 1 month more, targeting Sep 1. Dry run already ongoing.

Yes, ₹250-300 Cr achievable at 30% utilization by year-end. Month-on-month customer orders, no long-term POs.

Not doing anything unique. Restructuring team, getting distributors, building trust. Same approach as competitors but rebuilding after family issues.

Nothing as of now. They joined this month. Strategic partner only. Tech transfer maybe in 3-4 months, 'don't know.' Acrylic orders 'hopeful' but unconfirmed.

Can't separate margins due to common production. Margins will remain 'the same.' We stopped domestic losses; that's the improvement.

We stopped losses happening since many quarters. Restructuring will take 3-6 months; adding distributors, markets, cities.

Phenol ~$1,400/ton, melamine $1,000-1,100. Can't predict; depends on war. If war stops, 6-9 months to normalize.

Europe doing well, APAC and Middle East expanding. Will grow existing + add new. Logistics challenges global, not Stylam-specific.

Q1 at 15.4% YoY suggests back-loaded growth. New plant commercial from Sep 1 (month 5/6 of FY). Domestic turnaround from Q3. Achievable if both execute.

Quantified multi-year target; mechanism is funded capex (dry run active). Timing risk if domestic or export demand disappoints.

Q1 margin beat suggests room; management being conservative to avoid commit on domestic margin improvement. Raw material stable (phenol $1,400/ton, melamine $1,000-1,100).

Management said next capex after Q1-Q2 (after new plant ramps). Aica stake already paid; no additional financing needed.

Delayed Nov 2025 → Aug → Sep. Management blamed rain, family problems, construction complexity. Dry run active, but history of slippage creates doubt on timing.

Domestic stuck at ₹300 Cr for 4 years. Q1 low single-digit growth despite price hikes. Management plan is generic (team, distributors, warehouses) with no differentiation vs competitors.

40% stake taken July 2026, board representation active, but 'nothing as of now.' Tech transfer 'don't know' timeline. Acrylic sales from Aica 'hopeful' but unconfirmed. Partnership could yield or be passive financial investment.

Q1 growth 15.4% vs full-year 20-25% guidance. New plant contributes from Sep 1 (month 5), domestic turnaround from Q3. If either slips, FY target missed.

Phenol ~$1,400/ton, melamine $1,000-1,100/ton. War ongoing; management can't predict. If escalates, 6-9 months for normalization post-war.